HK Stock MarketDetailed Quotes

VIVA BIOTECH (01873)

Watchlist
  • 1.560
  • +0.020+1.30%
Market Closed May 7 16:01 CST
3.32BMarket Cap13.68P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

VIVA BIOTECH (01873) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
CDMO及商业化服务880.8M50.93%
药物发现服务839.34M48.53%
维亚生物创新中心9.31M0.54%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
CDMO及商业化服务880.8M50.93%
药物发现服务839.34M48.53%
维亚生物创新中心9.31M0.54%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
United States of America.830.8M48.04%
EU461.28M26.67%
The mainland of China259.65M15.01%
中国内地以外其他亚洲国家及地区92.27M5.34%
Other countries / regions67.63M3.91%
Africa17.82M1.03%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.10%
Sample Name
Sample Code
 +2.18%
Sample Name
Sample Code
 +1.23%
4
CNOOC
00883
+1.15%
5
SINOPEC CORP
00386
-1.48%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +68.99%
Sample Name
Sample Code
 +59.23%
Sample Name
Sample Code
 +44.37%
4
Emdoor Information
001314
+43.99%
5
Digital China Group
000034
+29.13%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -